The role of dopamine in reward and pleasure behaviour - review of data from preclinical research

被引:174
作者
Bressan, RA
Crippa, JA
机构
[1] Univ Fed Sao Paulo, UNIFESP, Dept Psychiat, Interdisciplinary Lab Neuroimaging & Cognit,LiNC, BR-04023900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol Psychiat & Psychol Med, Sao Paulo, Brazil
关键词
dopamine; reward system; dysphoria; depression; anhedonia; schizophrenia;
D O I
10.1111/j.1600-0447.2005.00540.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The purpose of this article is to review some of the basic aspects of the dopaminergic system and its role in reward and pleasure behaviour. We also discuss the association between dopamine and unpleasant symptoms that are commonly found in neuropsychiatric disorders and may also be side-effects of neuroleptic drugs. Method: A computer-based search of the literature, augmented by extensive bibliography-guided article reviews, were used to find basic information on the dopamine and the reward systems, and symptoms such as dysphoria, anhedonia and depression. Results: Central dopaminergic neurotransmission is complex, having multiple actions at each level of the mesocorticolimbic reward pathway. The role of dopamine in the reward process was classically associated with the ability to experience pleasure; recent data suggest a more motivational role. Dysfunction of the dopamine transmission in the reward circuit is associated with symptoms such as anhedonia, apathy and dysphoria found in several neuropsychiatric disorders, including Parkinson's disease, depression, drug addiction, and neuroleptic-induced dysphoria. Conclusion: Viewing the dysfunctions of the reward pathways within a broader spectrum and exploring its complex relations with the dopaminergic transmission may help understand the pathophysiology of these neuropsychiatric disorders and lead to a rational development of novel treatments.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 60 条
[1]   Increased baseline occupancy of D2 receptors by dopamine in schizophrenia [J].
Abi-Dargham, A ;
Rodenhiser, J ;
Printz, D ;
Zea-Ponce, Y ;
Gil, R ;
Kegeles, LS ;
Weiss, R ;
Cooper, TB ;
Mann, JJ ;
Van Heertum, RL ;
Gorman, JM ;
Laruelle, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8104-8109
[2]   SCH 23390 BLOCKS DRUG-CONDITIONED PLACE-PREFERENCE AND PLACE-AVERSION - ANHEDONIA (LACK OF REWARD) OR APATHY (LACK OF MOTIVATION) AFTER DOPAMINE-RECEPTOR BLOCKADE [J].
ACQUAS, E ;
CARBONI, E ;
LEONE, P ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1989, 99 (02) :151-155
[3]   COMPARATIVE PSYCHOTOMIMETIC EFFECTS OF STEREOISOMERS OF AMPHETAMINE [J].
ANGRIST, BM ;
SHOPSIN, B ;
GERSHON, S .
NATURE, 1971, 234 (5325) :152-&
[4]  
[Anonymous], 1980, GEN PSYCHOPATHOLOGY
[6]  
Bannon Michael J., 1995, P179
[7]   What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? [J].
Berridge, KC ;
Robinson, TE .
BRAIN RESEARCH REVIEWS, 1998, 28 (03) :309-369
[8]   BOTH SPLICING VARIANTS OF THE DOPAMINE-D2 RECEPTOR MESSENGERRNA ARE UP-REGULATED BY ANTIPSYCHOTIC-DRUGS [J].
BUCKLAND, PR ;
ODONOVAN, MC ;
MCGUFFIN, P .
NEUROSCIENCE LETTERS, 1993, 150 (01) :25-28
[9]   PRESENCE OF 3-HYDROXYTYRAMINE IN BRAIN [J].
CARLSSON, A ;
LINDQVIST, M ;
MAGNUSSON, T ;
WALDECK, B .
SCIENCE, 1958, 127 (3296) :471-471
[10]   DOES DOPAMINE PLAY A ROLE IN SCHIZOPHRENIA [J].
CARLSSON, A .
PSYCHOLOGICAL MEDICINE, 1977, 7 (04) :583-597